Literature DB >> 1528348

Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension.

R Bigazzi1, S Bianchi, V M Campese, G Baldari.   

Abstract

To determine the prevalence of increased urinary albumin excretion (UAE) in essential hypertension and to establish whether this abnormality is associated with deranged renal function, we have measured UAE in a group of 123 patients with essential hypertension and in 110 normal subjects. Mean arterial pressure (MAP) was 96 +/- 0.6 mm Hg in normal subjects and 121 +/- 0.3 mm Hg in patients with essential hypertension (p less than 0.01). Mean UAE was 8.6 +/- 0.5 in normal subjects and 32.9 +/- 3.3 mg/24 h in patients with essential hypertension (p less than 0.01). Forty percent of patients with essential hypertension manifested a UAE exceeding 30 mg/24 h and had an average UAE of 72.0 +/- 4.7 mg/24 h. MAP in patients with increased UAE was similar to that in subjects with normal UAE (121 +/- 0.5 vs. 121 +/- 0.4 mm Hg). Creatinine clearance was also not different between these two groups (91 +/- 1.8 vs. 94 +/- 1.5 ml/min). No correlation was found between UAE and MAP or creatinine clearance. Long-term prospective studies are needed to extablish whether an increase in UAE may predict future nephrosclerosis in essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1528348     DOI: 10.1159/000186842

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  11 in total

Review 1.  Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.

Authors:  Christine R Culy; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women.

Authors:  A Juutilainen; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  Diabetologia       Date:  2005-12-20       Impact factor: 10.122

Review 3.  Treatment of patients with essential hypertension and microalbuminuria.

Authors:  J Redon
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

4.  Cigarette smoking, proteinuria, and renal function in middle-aged Japanese men from an occupational population.

Authors:  Yuka Noborisaka; Masao Ishizaki; Minori Nakata; Yuichi Yamada; Ryumon Honda; Hitoshi Yokoyama; Masaru Miyao; Masaji Tabata
Journal:  Environ Health Prev Med       Date:  2011-08-24       Impact factor: 3.674

5.  Effect of amlodipine and lisinopril on microalbuminuria in patients with essential hypertension: A prospective study.

Authors:  S Jalal; F A Sofi; S M Abass; M S Alai; M A Bhat; H A Rather; N A Lone; M A Siddiqi
Journal:  Indian J Nephrol       Date:  2010-01

6.  Incidence of microalbuminuria in hypertensive patients.

Authors:  Ravjit Kaur Sabharwal; Parduman Singh; M M Arora; B L Somani; Vivek Ambade
Journal:  Indian J Clin Biochem       Date:  2008-03-06

7.  Effects of verapamil slow release plus trandolapril combination therapy on essential hypertension.

Authors:  Ulver Derici; Sukru Sindel; Turgay Arinsoy; Musa Bali; Berna Goker; Mustafa Cemri; Enver Hasanoglu
Journal:  Curr Ther Res Clin Exp       Date:  2003-01

8.  Does consumption of an aqueous extract of Hibscus sabdariffa affect renal function in subjects with mild to moderate hypertension?

Authors:  Daniel Chukwu Nwachukwu; Eddy Ikemefuna Aneke; Nkiru Zuada Nwachukwu; Nkiru Azubike; Lenard Fidelis Obika
Journal:  J Physiol Sci       Date:  2016-05-24       Impact factor: 2.781

9.  Correlation between blood pressure changes assessed by 24-hour ambulatory blood pressure monitoring and urine microalbuminuria excretion rate in normal and essential hypertension.

Authors:  I S Park; J H Shin; S J Hong
Journal:  Korean J Intern Med       Date:  1994-01       Impact factor: 2.884

10.  Endothelins and markers of renal damage in recently diagnosed hypertensive patients.

Authors:  Antonia Maldonado-Martín; Dolores Rueda-Illescas; Blas Gil-Extremera; Leticia Soriano-Carrascosa; Trinidad Alonso-Morales; Francisco García-Pérez; José García-Chicano; Juan de Dios Luna del Castillo
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Sep-Oct       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.